Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity
- PMID: 6785416
Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity
Abstract
The purpose of this study was to gain further insight into the mechanism of action of the anticonvulsant sodium valproate. The effects of valproate on spontaneous neuronal activity and its interaction with locally applied gamma-aminobutyric acid (GABA) were assessed in the rat cerebral cortex. Extracellular neuronal potentials were recorded using standard procedures. Valproate, glycine, GABA and bicuculline methiodide were applied through microiontophoresis. Valproate at 30, 50, and 100 nA did not affect the spontaneous activity of the majority of cells (21), increased the firing rate in four and slowed right cells. When applied simultaneously with GABA, valproate significantly enhanced GABA inhibition in a dose-related manner. Bicuculline methiodide antagonized the combined effects of valproate and GABA. Glycine inhibitions were not significantly enhanced by valproate. Our results indicate that valproate enhances GABA inhibition in the cerebral cortex, an action which is independent of its effect on spontaneous activity. The specificity of valproate for GABA suggests that this interaction may be an important mechanism through which valproate exerts its anticonvulsant properties.
Similar articles
-
The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity.Br J Pharmacol. 1980;71(2):545-51. doi: 10.1111/j.1476-5381.1980.tb10971.x. Br J Pharmacol. 1980. PMID: 6781578 Free PMC article.
-
Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture.J Pharmacol Exp Ther. 1986 Jun;237(3):1001-11. J Pharmacol Exp Ther. 1986. PMID: 3086538
-
Effect of sodium valproate on hypothalamic neurons in vivo and in vitro.Brain Res. 1981 Aug 24;219(1):231-7. doi: 10.1016/0006-8993(81)90288-2. Brain Res. 1981. PMID: 6790130
-
Valproate and myoclonus.Adv Neurol. 1986;43:661-74. Adv Neurol. 1986. PMID: 3080855 Review.
-
Pharmacology of valproate.Psychopharmacol Bull. 2003;37 Suppl 2:17-24. Psychopharmacol Bull. 2003. PMID: 14624230 Review.
Cited by
-
Mechanisms of anticonvulsant drug action. II. Drugs primarily used for absence epilepsy.Eur J Pediatr. 1987 Jan;146(1):8-14. doi: 10.1007/BF00647274. Eur J Pediatr. 1987. PMID: 3107994 Review.
-
Effects of valproate on hyponeophagia in rats: competitive antagonism with picrotoxin and non-competitive antagonism with RO 15-1788.Psychopharmacology (Berl). 1985;86(3):313-7. doi: 10.1007/BF00432220. Psychopharmacology (Berl). 1985. PMID: 2994145
-
Sodium valproate stimulates potassium and chloride urinary excretion in rats: gender differences.BMC Pharmacol. 2007 Aug 6;7:9. doi: 10.1186/1471-2210-7-9. BMC Pharmacol. 2007. PMID: 17683602 Free PMC article.
-
Comparison of the efficacy of two anticonvulsants, phenytoin and valproate to improve PCP and d-amphetamine induced deficits in a reversal learning task in the rat.Front Behav Neurosci. 2009 Jun 11;3:8. doi: 10.3389/neuro.08.008.2009. eCollection 2009. Front Behav Neurosci. 2009. PMID: 19562089 Free PMC article.
-
Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex.Psychopharmacology (Berl). 2006 Apr;185(2):255-62. doi: 10.1007/s00213-006-0317-3. Epub 2006 Feb 22. Psychopharmacology (Berl). 2006. PMID: 16496131